Lead Sponsor

Pfizer

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Subjects who met study entry criteria and completed 8-week induction treatment from Study A3921094 or A3921095
•Subjects who achieved clinical response in Study A3921094 or A3921095
•Women of childbearing potential must test negative for pregnancy prior to study enrollment
•Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
•Evidence of a personally signed and dated informed consent document(s) indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the study.

•Subjects who had major protocol violation (as determined by the Sponsor) in Study A3921094 or A3921095
•Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings suggestive of Crohn's disease
•Subjects who have had surgery for UC or in the opinion of the investigator, are likely to require surgery for UC during the study period.

Related studies

NCT06979336 · Ulcerative Colitis

NCT06937086 · Ulcerative Colitis, Obesity or Overweight

NCT07593352 · IBD and Renal Involement, Chronic Kidney Disease, and more

NCT06100289 · Ulcerative Colitis, Crohn's Disease

NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more

A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis